April 12, 2024
As part of the reauthorizations of the Prescription Drug User Fee Act (PDUFA VII) and the Biosimilar User Fee Act (BsUFA III), the Food and Drug […]
April 12, 2024
Abacavir/ dolutegravir/ lamivudine ViiV Healthcare Company 6/7/2023 Abatacept BMS 2/14/2017 Acetaminophen Mallinckrodt 7/11/2016 Afatinib Boehringer Ingelheim Pharmaceuticals, Inc. 3/8/2022 Aflibercept Regeneron Pharmaceuticals 10/18/2022 Albuterol GlaxoSmithKline 8/27/2008 […]
April 12, 2024
BUDAPEST — Low- to moderate-intensity physical exercise in patients with severe mental illness is linked to improved medication adherence, regardless of medication type or duration of […]
April 12, 2024
3/27/2024 3007621329 Zydus Lifesciences Limited 483 India 4/12/2024 4/4/2024 3002806710 Cipla Limited 483 India 4/10/2024 3/27/2024 3006370533 Alkem Laboratories Limited 483 India 4/9/2024 2/2/2024 3006895982 Jubilant […]
April 12, 2024
Docket Number: FDA-2022-D-0738 Issued by: Guidance Issuing Office Office of the Commissioner, Office of Clinical Policy and Programs, Office of Pediatric Therapeutics Center for Biologics Evaluation […]
April 12, 2024
San Diego — Data from an open-label extension study of delgocitinib cream reflects the positive phase 3 safety and efficacy results released > 1 year ago […]
April 12, 2024
TOPLINE: A recent survey highlighted ethical concerns US oncologists have about using artificial intelligence (AI) to help make cancer treatment decisions and revealed some contradictory views […]
April 12, 2024
ATLANTA — A investigative drug that uses a novel pathway to target cardiac metabolism was safe and well-tolerated and showed a signal to improve cardiac function […]
April 12, 2024
A rigorously conducted trial in men with androgenetic alopecia found that low-dose oral minoxidil was as effective in promoting hair growth as was topical minoxidil. Oral […]